The current understanding is that the liver is the primary contributory organ of circulating FGF21in the setting of metabolically unhealthy obesity with unelucidated impact of FGF21 as a myokine to the systemic milieu (Keuper et al., 2020). The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.